Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP)
Clinical trial NCT02868060 · COMPLETED
Trial details
- NCT number
- NCT02868060
- Sponsor
- Kyowa Kirin China Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-08-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.